Search For
/
Stocks
Intraday Booster
Sector Booster
Stock Screener
Market Pulse
Screeners
More
Go Prime
My Plans
Privacy Policy
Contact
Refer & EarnScreenersMain
Stock Screener
Create Screener
Explore Screeners
Community ScreenersTrading Screeners
CandleSticks Screener
Top Gainers & Losers
Opening Range Breakout
Stock Screener AI
Stock Quality Scorecard
Overvalued StocksNewUndervalued StocksNewTechnical Screeners
NR4 Stocks
NR7 Stocks
Previous Day High Breakout
Previous Day Low Breakout
Previous Day Open Breakout
Bullish Crossover Stocks
Bearish Crossover Stocks
High Volume Shocker
VWAP Breakout Stocks
Range High Breakout
Range Low BreakoutMoreMarkets
Global Market Today
Global Indices
Indian Indices
NIfty TodaySmart Money
FII DII DataNew
FII Buying
NSE Insider Trading
SLB Stocks DataDerivatives
FnO Movements
NSE F&O Lot Size
Ban ListAnalysis & Calendars
Technical DashboardSector Booster
Sector AnalysisNew
Result Calendar
Economic Calendar
CARE Ratings
Small Cap•563 Employees•IPO 2012
Current Price
₹1642.00
34.1 (2.12%)Updated
Valuation vs Sector
P/E Ratio
30.16vs 19.00
P/B Ratio
5.62vs 2.14
Div Yield
1.12%vs 0.57%
Today's Range
1562
₹1642.00
1647.7
52 Week Range
52W Low₹1052.00
52W High₹1964.00
₹1642.00
Downside56.08%
Upside19.61%
Price Chart
Compare with Peers
Historical Ratios
Track top 12 most important financial ratios
P/E Ratio: Price to Earnings - Most used valuation metric
Loading chart...
Analyzing Investment Quality
Processing 9 key metrics...
Key Metrics
Hover for details
Valuation
Market Cap
₹4,965.47 Cr
Market Cap
Total market value of companyP/E Ratio
30.85
P/E Ratio
Price to Earnings. Lower is generally better (<25 is good)P/B Ratio
5.30
P/B Ratio
Price to Book Value. <3 may indicate undervaluationEPS
₹53.45
EPS
Earnings Per Share. Higher and growing is positiveProfitability
ROE
11.90%
ROE
Return on Equity. >15% is good, >20% is excellentROCE
24.60%
ROCE
Return on Capital Employed. >15% is goodNet Margin
35.60%
Net Margin
Net profit as % of revenue. >10% is goodOperating Margin
-%
Operating Margin
Operating profit margin. >15% is goodGrowth
EPS Growth (5Y)
10.35%
EPS Growth (5Y)
5-year EPS growth. >15% is strongRevenue Growth (5Y)
10.55%
Revenue Growth (5Y)
5-year revenue growth. >10% is goodQtr Sales Growth
19.00%
Qtr Sales Growth
Quarter-over-quarter sales growthQtr Profit Growth
24.40%
Qtr Profit Growth
Quarter-over-quarter profit growthFinancial Health
Debt/Equity
0.03
Debt/Equity
Financial leverage. <1 is good, <0.5 is excellentBook Value
₹269.37
Book Value
Net asset value per shareDividend Yield
1.12%
Dividend Yield
Annual dividend as % of price. >2% is goodPromoter Holding
0.00%
Promoter Holding
Promoter stake. >50% shows confidenceGood
Average
Needs Attention
SWOT Analysis
Strengths
4 points- •CARE Ratings boasts a robust ROE of 18.00%, signifying efficient capital utilization and high returns for shareholders. This is complemented by a strong ROCE of 24.60% and a healthy OPM of 38.60%, indicating excellent profitability and operational efficiency.
- •The company demonstrates impressive quarterly growth, with a 19% increase in sales and a remarkable 24.4% surge in quarterly profits. This positive trajectory suggests strong market demand and effective operational management, promising continued growth.
Weaknesses
3 points- •The absence of promoter holdings (0%) raises significant concerns regarding corporate governance and the potential lack of long-term commitment from key stakeholders. This could negatively impact strategic decision-making and overall company stability.
- •CARE Ratings' P/E ratio of 33.20 suggests the stock might be richly valued relative to its earnings. This valuation warrants careful assessment for investors considering entry at the current price.
Opportunities
3 points- •The increasing institutional investor confidence, evidenced by rising FII holdings (from 17.47% to 23.61%) and DII holdings (from 21.53% to 31.60%) since 2022, presents an opportunity for enhanced market liquidity and valuation.
- •Expansion within the broader financial services sector, where CARE Ratings operates, could drive increased demand for credit rating services, allowing the company to capture a larger market share and boost revenue growth.
Threats
4 points- •Intense competition from established players like ICRA, which boasts a larger market cap and higher quarterly net profit, poses a significant threat to CARE Ratings' market share and pricing power in the ratings industry.
- •Potential adverse changes in regulatory policies governing the financial services and credit rating industry could impose stricter compliance requirements or limit operational flexibility, impacting profitability and growth prospects.
Segment-wise Financial Analysis
Fetching Financials...
Fetching Balance Sheet...
Fetching Cash Flow...
Shareholding Pattern
Loading shareholding data...
Company Insider Trading Activity
No insider trading data available
Corporate Action
Company Announcements
Technical Analysis & Indicators
Standard pivot points - most widely used
Pivot Points (CLASSIC)
| Level | Price | Distance | % Change |
|---|---|---|---|
| R4 | ₹1843.87 | +₹201.87 | +12.29% |
| R3 | ₹1758.17 | +₹116.17 | +7.07% |
| R2 | ₹1702.93 | +₹60.93 | +3.71% |
| R1 | ₹1672.47 | +₹30.47 | +1.86% |
| PIVOT | ₹1617.23 | -24.77 | -1.51% |
| CURRENT | ₹1642.00 | - | - |
| S1 | ₹1415.37 | -₹226.63 | -13.80% |
| S2 | ₹1501.07 | -₹140.93 | -8.58% |
| S3 | ₹1531.53 | -₹110.47 | -6.73% |
| S4 | ₹1586.77 | -₹55.23 | -3.36% |
CPR Levels
Support
Resistance
S4
N/A
S3
N/A
S2
N/A
S1
N/A
| CPR |
BC: N/AP: N/ATC: N/A
R1
N/A
R2
N/A
R3
N/A
R4
N/A
LTP: N/A
PDH: N/A
PDL: N/A
● Market Sentiment
is trading CPR, indicating
● CPR Width
CPR is
● Opening Range
Day's range: ~
● Price Position
Trading Inside opening range
Delivery Volume Analysis & Trading Activity
Latest Volume-54.3% vs avg
0.21L
(11 Mar 2026)Delivery %-11.1% vs avg
45.7%
(11 Mar 2026)Avg Volume (20D)20-day average
0.45L
(11 Feb - 11 Mar)Avg Delivery %Trend ↑
56.8%
(11 Feb - 11 Mar)Delivery % indicates the percentage of traded volume that resulted in actual delivery. Higher delivery % (>50%) suggests genuine buying interest and stronger hands.
Peer Comparison & Industry Benchmarking
Quick Compare
Largest by Market Cap
BSE Ltd
1.12L ₹ Cr
Best Profit Growth
BSE Ltd
100.00 %
Highest Dividend Yield
Indian Energy Exchange Ltd
2.37 %
Peer Comparison
| Company Name |
|---|
 BSE Ltd |
 CRISIL Ltd |
 ICRA Ltd |
 Indian Energy Exchange Ltd |
 Multi Commodity Exchange of India Ltd |
 Tracxn Technologies Ltd |
About
CARE Ratings Ltd
CARE Ratings Limited is a prominent credit rating agency operating within India and internationally. Its core business revolves around providing comprehensive creditworthiness assessments for a diverse range of financial instruments and entities. This encompasses a wide spectrum of services, enabling investors and other stakeholders to make informed decisions based on a thorough understanding of associated risks.
The company's rating services cover a vast array of financial products, including various debt instruments such as bank loans, bonds (both long-term and short-term), non-convertible debentures (NCDs), commercial papers, preference shares, and fixed deposits. They also rate more complex instruments like principal-protected market-linked debentures, subordinate debt, certificates of deposit (CDs) for banks, perpetual bonds, and hybrid instruments. Further extending their expertise, CARE Ratings provides ratings for mutual funds, structured finance arrangements, and insurance entities.
Beyond traditional credit ratings, CARE Ratings offers specialized services including recovery ratings, which assess the potential recovery value of defaulted debt. They also provide ratings for real estate investment trusts (REITs), infrastructure debt (infra EL), and public finance entities. The agency plays a vital role in the initial public offering (IPO) process, acting as a monitoring agency to ensure transparency and accuracy of information presented to potential investors.
Established in 1993 and headquartered in Mumbai, India, CARE Ratings Limited has a long history of providing crucial credit risk assessments. Formerly known as Credit Analysis and Research Limited, the company rebranded in June 2017 to its current name. The breadth of its services and its international reach solidify its position as a key player in the credit rating industry, providing essential information to support sound investment decisions and financial market stability.
COMPANY FACTS - CARERATING
Registered Address
4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off Eastern Express Highway, Sion (East)
Mumbai
MAHARASHTRA
IN
Tel: 912267543404
Website:https://www.careratings.com/
Investor Relations:http://www.careratings.com/financial-reports.aspx
Company Details
Group: Financial Services
Sector: Financials
Industry: Capital Markets
Exchange: NATIONAL STOCK EXCHANGE OF INDIA
Employees: 563
IPO Date: 26/12/2012
MANAGEMENT - CARERATING
Mr. Mehul Pandya
Chief Executive Officer, Managing Director, Executive Director
Mr. Jinesh Shah
Chief Financial Officer
Mr. Saurav Chatterjee
Co-Chief Executive Officer and Director of CARE Ratings (Africa) Private Limited
Ms. Sushmita Majumdar
Chief Executive Officer of CARE Advisory Research and Training Limited
Mr. Achin Nirwani
Chief Executive Officer of CARE Ratings Nepal Limited
Mr. Kiran Surve
Chief Executive Officer of CARE Risk Solutions Private Limited
Mr. Aniruddha Sen
Chief Human Resources Officer
Mr. Nadir Bhalwani
Chief Technology and Information Officer
Mr. Manoj Kumar
Compliance Officer, Company Secretary
Ms. Revati Kasture
Senior Director
Mr. Sachin Gupta
Executive Director, Chief Rating Officer
Ms. Rajani Sinha
Chief Economist
Investor Questions Answered
CARE Ratings Ltd (CARERATING) Stock FAQs
Get answers to the most common questions about CARE Ratings Ltd stock price, fundamentals, financial metrics, and investment analysis
The current share price of CARE Ratings Ltd (CARERATING) is ₹1,642. Today, the stock has gained by ₹34.10 (2.12%), trading in a range of ₹1,562 to ₹1,647.7. The stock opened at ₹1,595 with a trading volume of 31,895 shares.
CARE Ratings Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹4,965.47 crores, P/E ratio of 30.85, ROE of 11.90%, and ROCE of 24.60%. The dividend yield stands at 1.12%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
The 52-week high price of CARE Ratings Ltd (CARERATING) is ₹1,964, while the 52-week low is ₹1,052. Currently trading at ₹1,642, the stock is 64.7% away from its 52-week low and 16.4% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Whether to buy CARE Ratings Ltd stock at ₹1,642 depends on multiple factors. The stock is currently trading with a P/E ratio of 30.85 and P/B ratio of N/A. Today's performance shows a gain of 2.12%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
CARE Ratings Ltd offers a dividend yield of 1.12%, which means for every ₹100 invested at the current price of ₹1,642, you can expect to receive approximately ₹1.12 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
CARE Ratings Ltd's key financial metrics include: P/E Ratio: 30.85, P/B Ratio: N/A, ROE: 11.90%, ROCE: 24.60%, Dividend Yield: 1.12%, EPS: ₹53.45, Book Value: ₹269.37, Debt-to-Equity: 0.03, and Current Ratio: N/A. The company's market cap stands at ₹4,965.47 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
CARE Ratings Ltd stock opened at ₹1,595 and is currently trading at ₹1,642, showing a gain of ₹34.10 (2.12%). The intraday high is ₹1,647.7 and low is ₹1,562. The trading volume stands at 31,895 shares, indicating moderate market participation today.
CARE Ratings Ltd has a Price-to-Earnings (P/E) ratio of 30.85, which means investors are willing to pay ₹30.85 for every ₹1 of earnings. With an EPS of ₹53.45, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
CARE Ratings Ltd has a market capitalization of ₹4,965.47 crores, making it a small-cap company. Market cap is calculated by multiplying the current stock price (₹1,642) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
CARE Ratings Ltd has a book value of ₹269.37 per share and a Price-to-Book (P/B) ratio of N/A. The current market price is ₹1,642, which is 509.6% above the book value. A P/B ratio below 1 may indicate undervaluation or asset quality concerns.
CARE Ratings Ltd has a Return on Equity (ROE) of 11.90% and Return on Capital Employed (ROCE) of 24.60%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These are moderate returns, suggesting decent operational efficiency. Higher percentages generally indicate better financial performance.
CARE Ratings Ltd operates in the diversified sector and belongs to the general industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
CARE Ratings Ltd has a debt-to-equity ratio of 0.03, which measures the company's financial leverage by comparing total debt to shareholders' equity. A low ratio suggests conservative financing with minimal debt. Lower ratios generally indicate lower financial risk, but optimal levels vary by industry.
CARE Ratings Ltd has an Earnings Per Share (EPS) of ₹53.45, which represents the company's profit allocated to each outstanding share. With a current stock price of ₹1,642 and P/E ratio of 30.85, investors are paying 30.85 times the annual earnings per share. This strong EPS indicates robust profitability. Track EPS growth over quarters to assess earnings momentum.
CARE Ratings Ltd has reported a sales growth of N/A% and profit growth of N/A%. The company may be facing growth challenges or operating in a mature market. Consistent growth over multiple quarters is a positive indicator for long-term investors. Compare these growth rates with industry peers for better perspective.
CARE Ratings Ltd has a current ratio of N/A, which measures the company's ability to pay short-term obligations with current assets. A ratio below 1 may indicate potential liquidity concerns. This metric is crucial for assessing the company's working capital management and financial safety.
To analyze CARE Ratings Ltd stock, consider: 1) Fundamental Analysis - Review P/E (30.85), ROE (11.90%), debt-to-equity (0.03), and growth rates. 2) Technical Analysis - Check 52-week range (₹1052.00 - ₹1964.00), moving averages, and chart patterns. 3) Valuation - Compare current price (₹1642.00) with book value (₹269.37) and industry peers. 4) Financial Health - Assess current ratio (N/A) and cash flows. 5) Growth Prospects - Evaluate sales growth (N/A%) and profit growth (N/A%). Always diversify and consult a financial advisor.
The face value (or par value) of CARE Ratings Ltd share is ₹10.00. Face value is the nominal value of a share as stated in the company's charter and is used for accounting purposes and calculating dividends. The current market price of ₹1,642 is 16320x the face value. Face value remains constant unless the company undergoes a stock split or bonus issue, while market price fluctuates based on demand and supply.
Investing in CARE Ratings Ltd carries several risks: 1) Market Risk - Stock price volatility (52-week range: ₹1052.00 - ₹1964.00). 2) Business Risk - Industry-specific challenges in the sector. 3) Financial Risk - Debt-to-equity ratio of 0.03 indicates leverage. 4) Liquidity Risk - Based on trading volume of 31,895 shares. 5) Valuation Risk - P/E of 30.85 may indicate over/undervaluation. 6) Economic Risk - Macroeconomic factors affecting the industry. Diversify your portfolio and invest only what you can afford to lose.
CARE Ratings Ltd operates in the industry with key metrics: P/E ratio of 30.85, ROE of 11.90%, market cap of ₹4,965.47 crores, and dividend yield of 1.12%. To make an informed comparison, analyze these metrics against industry peers considering factors like revenue growth (N/A%), profit margins, debt levels (D/E: 0.03), and market position. Use our peer comparison tool on this page to see detailed side-by-side analysis with competitors.
Target prices for CARE Ratings Ltd vary among analysts and depend on multiple factors including earnings projections, industry trends, and market conditions. The stock is currently trading at ₹1,642, with a 52-week range of ₹1052.00 to ₹1964.00. Based on fundamentals like P/E (30.85), ROE (11.90%), and growth rates, analysts may have different target prices. Always refer to recent research reports from reputed brokerages and make decisions based on your own analysis and risk appetite.
Consider selling CARE Ratings Ltd stock when: 1) Target Price Achieved - If the stock reaches your predetermined target from current ₹1642.00. 2) Fundamental Deterioration - Declining ROE (currently 11.90%), increasing debt (D/E: 0.03), or falling growth rates. 3) Better Opportunities - Finding stocks with superior risk-reward ratios. 4) Portfolio Rebalancing - When the stock becomes overweight in your portfolio. 5) Changed Investment Thesis - If reasons for buying no longer hold. 6) Stop Loss - If price falls below your risk threshold. Always base decisions on thorough analysis rather than emotions.
Tax implications for CARE Ratings Ltd stock investments: 1) Short-term Capital Gains (STCG) - If sold within 1 year, gains taxed at 15% plus cess. 2) Long-term Capital Gains (LTCG) - If held over 1 year, gains above ₹1 lakh taxed at 10% without indexation. 3) Dividend Income - Dividends (current yield: 1.12%) are taxable as per your income tax slab. 4) Securities Transaction Tax (STT) - Applicable on both buy and sell transactions. 5) Intraday Trading - Treated as speculative income, taxed as per slab. Tax laws change periodically, so consult a tax advisor for personalized guidance and latest regulations.
Menu